Robotic Exoskeletons: Mobility & Job Assistance

Recent years have demonstrated significant advancements in robotic exoskeleton capabilities. This is easily understood, as this technology is among those that immediately appear poised to positively transform lives. Several demonstrations from various companies have been truly remarkable—witnessing an individual walk independently after years of immobility, with their loved ones overcome with emotion, is a powerful experience.

Furthermore, this technology addresses two primary applications. The first involves enhancing mobility, assisting those with paralysis or walking difficulties to move with greater ease. The second focuses on workplace support, with exoskeletons offering the potential to reduce strain from lifting heavy items or prolonged standing. Consequently, many organizations, such as Esko Bionics, have established separate divisions to cater to these distinct needs.

This represents a substantial potential market, although full maturation will require several years. Therefore, current estimates are necessarily preliminary. I believe there remains an opportunity for smaller companies to establish a viable presence within this field.

It would not be surprising to see larger corporations become more involved in this sector, as it provides a valuable opportunity to demonstrate innovation in robotics. Samsung’s GEMS is currently the most prominent product in this area, as showcased at CES, despite receiving limited presentation time. Initially unveiled at the event two years prior, we had the chance to evaluate it. Current updates focus on hardware enhancements, including battery improvements, and the initiation of clinical trials—an essential step in bringing this type of healthcare-related product to market.

As with most of Samsung’s robotics announcements at this year’s show, it remains uncertain how committed the company is to the product’s development. Last year, it featured briefly at CES as part of an “immersive workout experience.”

Several smaller companies have also presented promising innovations. Archelis Inc., a Japan-based firm, is particularly noteworthy, exhibiting the ArchelisFX, named after the Japanese term for “walkable chair.” This device is intended for various applications, including alleviating back pain and aiding recovery after surgery. The company anticipates offering it for rent or purchase at approximately $5,000.

Generally, the exoskeletons displayed at this year’s virtual CES primarily addressed mobility concerns. Sarcos Robotics, which announced a collaboration with Delta Airlines at the previous year’s event, was notably absent. In September, the company leveraged this interest to secure $40 million in funding.